期刊文献+

新药替莫唑胺酯抗原发性耐药胶质瘤机制研究 被引量:5

Mechanism of New Drug Temozolomide Easter on Primary Resistance Glioma
原文传递
导出
摘要 目的以替莫唑胺(temozolomide,TMZ)为阳性对照,研究新药替莫唑胺酯(temozolomide hexyl ester,TMZ-HE)在体外抑制脑胶质瘤T98G细胞生长并诱导凋亡的作用及其机制。方法 MTT比色法和克隆形成实验比较TMZ和TMZ-HE对细胞增殖的影响;流式细胞仪检测TMZ-HE和TMZ对细胞凋亡率及细胞周期的影响;Western blot检测TMZ和TMZ-HE对Bax、Bcl-2以及O^6-甲基鸟嘌呤-DNA甲基转移酶(O^6-methyl-oguanine-DNA-methyltransferase,MGMT)、γH2AX蛋白表达的影响。结果 TMZ-HE较TMZ明显抑制T98G细胞的生长,呈浓度及时间依赖性,长期作用时效果更加明显;TMZ-HE诱导T98G细胞凋亡率高于TMZ;TMZ-HE能够导致T98G细胞发生G2期阻滞;TMZ-HE能够增加Bax/Bcl-2的比值,诱导发生凋亡,TMZ-HE比TMZ更明显地消耗MGMT,产生更强的DNA损伤。结论 TMZ-HE对胶质瘤T98G细胞的增殖抑制及诱导凋亡的作用优于TMZ,消耗MGMT以及DNA损伤能力强于TMZ。 OBJECTIVE To investigate the effect of temozolomide(TMZ) hexyl easter(TMZ-HE) on the proliferation and apoptosis of brain glioma T98 G cells in vitro compared with TMZ, and then illustrate the mechanism. METHODS Methyl thiazolyl tetrazolium(MTT) assay and colony formation assay was used to compare the effect of TMZ and TMZ-HE on cell proliferation. Cell apoptosis rate and cell cycle induced by TMZ and TMZ-HE were analyzed by flow cytometry. Western blot was used to detect the expression of Bax, Bcl-2, O^6-methyl-oguanine-DNA-methyltransferase(MGMT), γH2AX after treated with TMZ and TMZ-HE. RESULTS TMZ-HE obviously suppressed the cell proliferation in a concentration and time-dependent manner compared with TMZ, and it was more obvious in long-term effect; TMZ-HE induced more cellular apoptosis of the T98 G cells than TMZ; TMZ-HE induced a distinct G2 arrest in T98 G cell; TMZ-HE induced apoptosis by increasing the ratio of Bax/Bcl-2, TMZ-HE consumed MGMT more significant than TMZ, and produced more DNA damage. CONCLUSION TMZ-HE has an advantage over the effect of anti-proliferative and induced apoptosis than TMZ, and the ability of TMZ-HE to consume MGMT and DNA damage is improved.
出处 《中国现代应用药学》 CAS CSCD 2016年第1期27-32,共6页 Chinese Journal of Modern Applied Pharmacy
基金 十二五“重大新药创制”科技重大专项课题(2013ZX09303001)
关键词 替莫唑胺酯 多形性脑胶质瘤 细胞凋亡 耐药 temozolomide hexyl ester glioblastoma multiforme cell apoptosis resistance
  • 相关文献

参考文献17

  • 1OHGAKI H, KLEIHUES P. Genetic pathways to primary andsecondary glioblastoma [J], Am J Pathol, 2007,170(5):1445-1453.
  • 2OHGAKI H, DESSEN P, JOURDE B, et al. Genetic pathwaysto glioblastoma: a population-based study [J]. Cancer Res,2004,64(19): 892-899.
  • 3FUKAI J,KOIZUMI F, NAKAO N. Enhanced anti-tumoreffect of zoledronic acid combined with temozolomide againsthuman malignant glioma cell expressing 06-methylguanineDNA methyltransferase [J]. PLoS One, 2014, 9(8): 1038-1045.
  • 4FU D, CALVO J A, SAMSON L D. Balancing repair andtolerance of DNA damage caused by alkylating agents [J]. NatRev Cancer, 2012, 12(2): 104-120.
  • 5CASTRO G N, CAYADO-GUTIERREZ N, ZOPPINO F C, etal. Effects of temozolomide (TMZ) on the expression andinteraction of heat shock proteins (HSPs) and DNA repairproteins in human malignant glioma cells [J]. Cell StressChaperones, 2015, 20(2): 253-265.
  • 6JIAO Y, LI H, LIU Y, et al. Resveratrol Inhibits the Invasionof glioblastoma-initiating cells via down-regulation of thePI3K/Akt/NF-kappaB signaling pathway [J]. Nutrients, 2015,7(6): 4383-4402.
  • 7SUPPASANSATORN P, WANG G, CONWAY B R, et al.Skin delivery potency and antitumor activities oftemozolomide ester prodrugs [J]. Cancer Lett, 2006,244(1):42-50.
  • 8FARES M, ABEDI-VALUGERDI M, HASSAN M, et al.DNA damage, lysosomal degradation and Bcl-xL deamidationin doxycycline- and minocycline-induced cell death in theK562 leukemic cell line [J]. Biochem Biophys Res Commun,2015,103(12): 1781-1792.
  • 9DARZYNKIEWICZ Z, ZHAO H, HALICKA H D, et al. DNAdamage signaling assessed in individual cells in relation to thecell cycle phase and induction of apoptosis [J]. Crit Rev ClinLab Sci, 2012, 49(5): 199-217.
  • 10WIEWRODT D, NAGEL G, DREIMULLER N, et al. MGMTin primary and recurrent human glioblastomas after radiationand chemotherapy and comparison with p53 status and clinicaloutcome [J]. Int J Cancer, 2008,122(6): 1391-1403.

同被引文献22

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部